nodes	percent_of_prediction	percent_of_DWPC	metapath
Formoterol—CYP2D6—Alzheimer's disease	0.277	1	CbGaD
Formoterol—CYP2A6—Memantine—Alzheimer's disease	0.165	0.349	CbGbCtD
Formoterol—CYP2D6—Rivastigmine—Alzheimer's disease	0.0749	0.159	CbGbCtD
Formoterol—CYP2C19—Memantine—Alzheimer's disease	0.0683	0.145	CbGbCtD
Formoterol—CYP2C9—Donepezil—Alzheimer's disease	0.0655	0.139	CbGbCtD
Formoterol—CYP2D6—Donepezil—Alzheimer's disease	0.0599	0.127	CbGbCtD
Formoterol—CYP2D6—Galantamine—Alzheimer's disease	0.0386	0.0817	CbGbCtD
Formoterol—Influenza—Memantine—Alzheimer's disease	0.000382	0.00177	CcSEcCtD
Formoterol—Asthma—Memantine—Alzheimer's disease	0.000382	0.00177	CcSEcCtD
Formoterol—Mental disorder—Galantamine—Alzheimer's disease	0.000381	0.00177	CcSEcCtD
Formoterol—Hyperglycaemia—Donepezil—Alzheimer's disease	0.00038	0.00176	CcSEcCtD
Formoterol—Malnutrition—Galantamine—Alzheimer's disease	0.000379	0.00176	CcSEcCtD
Formoterol—Bronchospasm—Memantine—Alzheimer's disease	0.000376	0.00175	CcSEcCtD
Formoterol—Angina pectoris—Memantine—Alzheimer's disease	0.000373	0.00173	CcSEcCtD
Formoterol—Tension—Galantamine—Alzheimer's disease	0.000372	0.00172	CcSEcCtD
Formoterol—Dysgeusia—Galantamine—Alzheimer's disease	0.000371	0.00172	CcSEcCtD
Formoterol—Acute coronary syndrome—Donepezil—Alzheimer's disease	0.00037	0.00172	CcSEcCtD
Formoterol—Myocardial infarction—Donepezil—Alzheimer's disease	0.000368	0.00171	CcSEcCtD
Formoterol—Bronchospasm—Rivastigmine—Alzheimer's disease	0.000368	0.00171	CcSEcCtD
Formoterol—Nervousness—Galantamine—Alzheimer's disease	0.000368	0.00171	CcSEcCtD
Formoterol—Bronchitis—Memantine—Alzheimer's disease	0.000368	0.00171	CcSEcCtD
Formoterol—Back pain—Galantamine—Alzheimer's disease	0.000366	0.0017	CcSEcCtD
Formoterol—Urinary tract infection—Donepezil—Alzheimer's disease	0.000365	0.00169	CcSEcCtD
Formoterol—Conjunctivitis—Donepezil—Alzheimer's disease	0.000365	0.00169	CcSEcCtD
Formoterol—Angina pectoris—Rivastigmine—Alzheimer's disease	0.000364	0.00169	CcSEcCtD
Formoterol—Muscle spasms—Galantamine—Alzheimer's disease	0.000364	0.00169	CcSEcCtD
Formoterol—Bronchitis—Rivastigmine—Alzheimer's disease	0.00036	0.00167	CcSEcCtD
Formoterol—Haematuria—Donepezil—Alzheimer's disease	0.000358	0.00166	CcSEcCtD
Formoterol—Upper respiratory tract infection—Memantine—Alzheimer's disease	0.000355	0.00165	CcSEcCtD
Formoterol—Tremor—Galantamine—Alzheimer's disease	0.000355	0.00165	CcSEcCtD
Formoterol—Ill-defined disorder—Galantamine—Alzheimer's disease	0.000351	0.00163	CcSEcCtD
Formoterol—Agitation—Galantamine—Alzheimer's disease	0.000348	0.00161	CcSEcCtD
Formoterol—Upper respiratory tract infection—Rivastigmine—Alzheimer's disease	0.000348	0.00161	CcSEcCtD
Formoterol—Hyperglycaemia—Memantine—Alzheimer's disease	0.000345	0.0016	CcSEcCtD
Formoterol—Malaise—Galantamine—Alzheimer's disease	0.000341	0.00158	CcSEcCtD
Formoterol—Rhinitis—Donepezil—Alzheimer's disease	0.000338	0.00157	CcSEcCtD
Formoterol—Hyperglycaemia—Rivastigmine—Alzheimer's disease	0.000337	0.00157	CcSEcCtD
Formoterol—Acute coronary syndrome—Memantine—Alzheimer's disease	0.000336	0.00156	CcSEcCtD
Formoterol—Palpitations—Galantamine—Alzheimer's disease	0.000335	0.00155	CcSEcCtD
Formoterol—Pharyngitis—Donepezil—Alzheimer's disease	0.000335	0.00155	CcSEcCtD
Formoterol—Myocardial infarction—Memantine—Alzheimer's disease	0.000334	0.00155	CcSEcCtD
Formoterol—Urinary tract disorder—Donepezil—Alzheimer's disease	0.000333	0.00154	CcSEcCtD
Formoterol—Oedema peripheral—Donepezil—Alzheimer's disease	0.000332	0.00154	CcSEcCtD
Formoterol—Conjunctivitis—Memantine—Alzheimer's disease	0.000331	0.00154	CcSEcCtD
Formoterol—Urinary tract infection—Memantine—Alzheimer's disease	0.000331	0.00154	CcSEcCtD
Formoterol—Urethral disorder—Donepezil—Alzheimer's disease	0.00033	0.00153	CcSEcCtD
Formoterol—Cough—Galantamine—Alzheimer's disease	0.00033	0.00153	CcSEcCtD
Formoterol—Acute coronary syndrome—Rivastigmine—Alzheimer's disease	0.000329	0.00153	CcSEcCtD
Formoterol—Myocardial infarction—Rivastigmine—Alzheimer's disease	0.000327	0.00152	CcSEcCtD
Formoterol—Hypertension—Galantamine—Alzheimer's disease	0.000327	0.00152	CcSEcCtD
Formoterol—Haematuria—Memantine—Alzheimer's disease	0.000325	0.00151	CcSEcCtD
Formoterol—Visual impairment—Donepezil—Alzheimer's disease	0.000325	0.00151	CcSEcCtD
Formoterol—Urinary tract infection—Rivastigmine—Alzheimer's disease	0.000324	0.0015	CcSEcCtD
Formoterol—Conjunctivitis—Rivastigmine—Alzheimer's disease	0.000324	0.0015	CcSEcCtD
Formoterol—Arthralgia—Galantamine—Alzheimer's disease	0.000322	0.0015	CcSEcCtD
Formoterol—Myalgia—Galantamine—Alzheimer's disease	0.000322	0.0015	CcSEcCtD
Formoterol—Chest pain—Galantamine—Alzheimer's disease	0.000322	0.0015	CcSEcCtD
Formoterol—Anxiety—Galantamine—Alzheimer's disease	0.000321	0.00149	CcSEcCtD
Formoterol—Unspecified disorder of skin and subcutaneous tissue—Galantamine—Alzheimer's disease	0.00032	0.00149	CcSEcCtD
Formoterol—Sinusitis—Memantine—Alzheimer's disease	0.00032	0.00148	CcSEcCtD
Formoterol—Discomfort—Galantamine—Alzheimer's disease	0.000319	0.00148	CcSEcCtD
Formoterol—Haematuria—Rivastigmine—Alzheimer's disease	0.000318	0.00148	CcSEcCtD
Formoterol—Dry mouth—Galantamine—Alzheimer's disease	0.000315	0.00146	CcSEcCtD
Formoterol—Sinusitis—Rivastigmine—Alzheimer's disease	0.000313	0.00145	CcSEcCtD
Formoterol—Rhinitis—Memantine—Alzheimer's disease	0.000307	0.00142	CcSEcCtD
Formoterol—Pharyngitis—Memantine—Alzheimer's disease	0.000304	0.00141	CcSEcCtD
Formoterol—Nervous system disorder—Galantamine—Alzheimer's disease	0.000303	0.00141	CcSEcCtD
Formoterol—Urinary tract disorder—Memantine—Alzheimer's disease	0.000302	0.0014	CcSEcCtD
Formoterol—Tachycardia—Galantamine—Alzheimer's disease	0.000302	0.0014	CcSEcCtD
Formoterol—Oedema peripheral—Memantine—Alzheimer's disease	0.000302	0.0014	CcSEcCtD
Formoterol—Arrhythmia—Donepezil—Alzheimer's disease	0.000301	0.0014	CcSEcCtD
Formoterol—Connective tissue disorder—Memantine—Alzheimer's disease	0.000301	0.0014	CcSEcCtD
Formoterol—Rhinitis—Rivastigmine—Alzheimer's disease	0.0003	0.00139	CcSEcCtD
Formoterol—Skin disorder—Galantamine—Alzheimer's disease	0.0003	0.00139	CcSEcCtD
Formoterol—Urethral disorder—Memantine—Alzheimer's disease	0.0003	0.00139	CcSEcCtD
Formoterol—Pharyngitis—Rivastigmine—Alzheimer's disease	0.000297	0.00138	CcSEcCtD
Formoterol—Urinary tract disorder—Rivastigmine—Alzheimer's disease	0.000296	0.00137	CcSEcCtD
Formoterol—Mental disorder—Donepezil—Alzheimer's disease	0.000295	0.00137	CcSEcCtD
Formoterol—Oedema peripheral—Rivastigmine—Alzheimer's disease	0.000295	0.00137	CcSEcCtD
Formoterol—Visual impairment—Memantine—Alzheimer's disease	0.000295	0.00137	CcSEcCtD
Formoterol—Connective tissue disorder—Rivastigmine—Alzheimer's disease	0.000294	0.00137	CcSEcCtD
Formoterol—Urethral disorder—Rivastigmine—Alzheimer's disease	0.000294	0.00136	CcSEcCtD
Formoterol—Malnutrition—Donepezil—Alzheimer's disease	0.000293	0.00136	CcSEcCtD
Formoterol—Hypotension—Galantamine—Alzheimer's disease	0.000289	0.00134	CcSEcCtD
Formoterol—Visual impairment—Rivastigmine—Alzheimer's disease	0.000289	0.00134	CcSEcCtD
Formoterol—Tension—Donepezil—Alzheimer's disease	0.000288	0.00134	CcSEcCtD
Formoterol—Dysgeusia—Donepezil—Alzheimer's disease	0.000287	0.00133	CcSEcCtD
Formoterol—Nervousness—Donepezil—Alzheimer's disease	0.000285	0.00132	CcSEcCtD
Formoterol—Cardiac disorder—Memantine—Alzheimer's disease	0.000284	0.00132	CcSEcCtD
Formoterol—Back pain—Donepezil—Alzheimer's disease	0.000284	0.00132	CcSEcCtD
Formoterol—Muscle spasms—Donepezil—Alzheimer's disease	0.000282	0.00131	CcSEcCtD
Formoterol—Musculoskeletal discomfort—Galantamine—Alzheimer's disease	0.000282	0.00131	CcSEcCtD
Formoterol—Insomnia—Galantamine—Alzheimer's disease	0.00028	0.0013	CcSEcCtD
Formoterol—Cardiac disorder—Rivastigmine—Alzheimer's disease	0.000278	0.00129	CcSEcCtD
Formoterol—Immune system disorder—Memantine—Alzheimer's disease	0.000276	0.00128	CcSEcCtD
Formoterol—Mediastinal disorder—Memantine—Alzheimer's disease	0.000276	0.00128	CcSEcCtD
Formoterol—Tremor—Donepezil—Alzheimer's disease	0.000275	0.00128	CcSEcCtD
Formoterol—Somnolence—Galantamine—Alzheimer's disease	0.000275	0.00127	CcSEcCtD
Formoterol—Arrhythmia—Memantine—Alzheimer's disease	0.000273	0.00127	CcSEcCtD
Formoterol—Ill-defined disorder—Donepezil—Alzheimer's disease	0.000272	0.00126	CcSEcCtD
Formoterol—Dyspepsia—Galantamine—Alzheimer's disease	0.000272	0.00126	CcSEcCtD
Formoterol—Mediastinal disorder—Rivastigmine—Alzheimer's disease	0.00027	0.00125	CcSEcCtD
Formoterol—Agitation—Donepezil—Alzheimer's disease	0.00027	0.00125	CcSEcCtD
Formoterol—Mental disorder—Memantine—Alzheimer's disease	0.000268	0.00124	CcSEcCtD
Formoterol—Arrhythmia—Rivastigmine—Alzheimer's disease	0.000267	0.00124	CcSEcCtD
Formoterol—Gastrointestinal disorder—Galantamine—Alzheimer's disease	0.000267	0.00124	CcSEcCtD
Formoterol—Malnutrition—Memantine—Alzheimer's disease	0.000266	0.00124	CcSEcCtD
Formoterol—Fatigue—Galantamine—Alzheimer's disease	0.000266	0.00124	CcSEcCtD
Formoterol—Malaise—Donepezil—Alzheimer's disease	0.000265	0.00123	CcSEcCtD
Formoterol—Constipation—Galantamine—Alzheimer's disease	0.000264	0.00123	CcSEcCtD
Formoterol—Mental disorder—Rivastigmine—Alzheimer's disease	0.000262	0.00122	CcSEcCtD
Formoterol—Tension—Memantine—Alzheimer's disease	0.000261	0.00121	CcSEcCtD
Formoterol—Dysgeusia—Memantine—Alzheimer's disease	0.000261	0.00121	CcSEcCtD
Formoterol—Malnutrition—Rivastigmine—Alzheimer's disease	0.000261	0.00121	CcSEcCtD
Formoterol—Nervousness—Memantine—Alzheimer's disease	0.000259	0.0012	CcSEcCtD
Formoterol—Back pain—Memantine—Alzheimer's disease	0.000258	0.0012	CcSEcCtD
Formoterol—Cough—Donepezil—Alzheimer's disease	0.000256	0.00119	CcSEcCtD
Formoterol—Tension—Rivastigmine—Alzheimer's disease	0.000256	0.00119	CcSEcCtD
Formoterol—Dysgeusia—Rivastigmine—Alzheimer's disease	0.000255	0.00118	CcSEcCtD
Formoterol—Feeling abnormal—Galantamine—Alzheimer's disease	0.000255	0.00118	CcSEcCtD
Formoterol—Hypertension—Donepezil—Alzheimer's disease	0.000253	0.00118	CcSEcCtD
Formoterol—Nervousness—Rivastigmine—Alzheimer's disease	0.000253	0.00117	CcSEcCtD
Formoterol—Gastrointestinal pain—Galantamine—Alzheimer's disease	0.000253	0.00117	CcSEcCtD
Formoterol—Back pain—Rivastigmine—Alzheimer's disease	0.000252	0.00117	CcSEcCtD
Formoterol—Muscle spasms—Rivastigmine—Alzheimer's disease	0.000251	0.00116	CcSEcCtD
Formoterol—Chest pain—Donepezil—Alzheimer's disease	0.00025	0.00116	CcSEcCtD
Formoterol—Arthralgia—Donepezil—Alzheimer's disease	0.00025	0.00116	CcSEcCtD
Formoterol—Myalgia—Donepezil—Alzheimer's disease	0.00025	0.00116	CcSEcCtD
Formoterol—Tremor—Memantine—Alzheimer's disease	0.00025	0.00116	CcSEcCtD
Formoterol—Anxiety—Donepezil—Alzheimer's disease	0.000249	0.00116	CcSEcCtD
Formoterol—Ill-defined disorder—Memantine—Alzheimer's disease	0.000247	0.00115	CcSEcCtD
Formoterol—Discomfort—Donepezil—Alzheimer's disease	0.000247	0.00115	CcSEcCtD
Formoterol—Agitation—Memantine—Alzheimer's disease	0.000245	0.00114	CcSEcCtD
Formoterol—Dry mouth—Donepezil—Alzheimer's disease	0.000244	0.00113	CcSEcCtD
Formoterol—Abdominal pain—Galantamine—Alzheimer's disease	0.000244	0.00113	CcSEcCtD
Formoterol—Body temperature increased—Galantamine—Alzheimer's disease	0.000244	0.00113	CcSEcCtD
Formoterol—Tremor—Rivastigmine—Alzheimer's disease	0.000244	0.00113	CcSEcCtD
Formoterol—Ill-defined disorder—Rivastigmine—Alzheimer's disease	0.000242	0.00112	CcSEcCtD
Formoterol—Malaise—Memantine—Alzheimer's disease	0.00024	0.00112	CcSEcCtD
Formoterol—Agitation—Rivastigmine—Alzheimer's disease	0.00024	0.00111	CcSEcCtD
Formoterol—Oedema—Donepezil—Alzheimer's disease	0.00024	0.00111	CcSEcCtD
Formoterol—Infection—Donepezil—Alzheimer's disease	0.000238	0.0011	CcSEcCtD
Formoterol—Palpitations—Memantine—Alzheimer's disease	0.000235	0.00109	CcSEcCtD
Formoterol—Malaise—Rivastigmine—Alzheimer's disease	0.000235	0.00109	CcSEcCtD
Formoterol—Nervous system disorder—Donepezil—Alzheimer's disease	0.000235	0.00109	CcSEcCtD
Formoterol—Cough—Memantine—Alzheimer's disease	0.000233	0.00108	CcSEcCtD
Formoterol—Palpitations—Rivastigmine—Alzheimer's disease	0.00023	0.00107	CcSEcCtD
Formoterol—Hypertension—Memantine—Alzheimer's disease	0.00023	0.00107	CcSEcCtD
Formoterol—Hypersensitivity—Galantamine—Alzheimer's disease	0.000228	0.00106	CcSEcCtD
Formoterol—Cough—Rivastigmine—Alzheimer's disease	0.000227	0.00106	CcSEcCtD
Formoterol—Arthralgia—Memantine—Alzheimer's disease	0.000227	0.00105	CcSEcCtD
Formoterol—Myalgia—Memantine—Alzheimer's disease	0.000227	0.00105	CcSEcCtD
Formoterol—Chest pain—Memantine—Alzheimer's disease	0.000227	0.00105	CcSEcCtD
Formoterol—Anxiety—Memantine—Alzheimer's disease	0.000226	0.00105	CcSEcCtD
Formoterol—Hypertension—Rivastigmine—Alzheimer's disease	0.000225	0.00104	CcSEcCtD
Formoterol—Discomfort—Memantine—Alzheimer's disease	0.000224	0.00104	CcSEcCtD
Formoterol—Hypotension—Donepezil—Alzheimer's disease	0.000224	0.00104	CcSEcCtD
Formoterol—Arthralgia—Rivastigmine—Alzheimer's disease	0.000222	0.00103	CcSEcCtD
Formoterol—Chest pain—Rivastigmine—Alzheimer's disease	0.000222	0.00103	CcSEcCtD
Formoterol—Myalgia—Rivastigmine—Alzheimer's disease	0.000222	0.00103	CcSEcCtD
Formoterol—Dry mouth—Memantine—Alzheimer's disease	0.000222	0.00103	CcSEcCtD
Formoterol—Asthenia—Galantamine—Alzheimer's disease	0.000222	0.00103	CcSEcCtD
Formoterol—Anxiety—Rivastigmine—Alzheimer's disease	0.000221	0.00103	CcSEcCtD
Formoterol—Unspecified disorder of skin and subcutaneous tissue—Rivastigmine—Alzheimer's disease	0.00022	0.00102	CcSEcCtD
Formoterol—Arformoterol—CYP2D6—Alzheimer's disease	0.00022	0.578	CrCbGaD
Formoterol—Discomfort—Rivastigmine—Alzheimer's disease	0.000219	0.00102	CcSEcCtD
Formoterol—Musculoskeletal discomfort—Donepezil—Alzheimer's disease	0.000218	0.00101	CcSEcCtD
Formoterol—Oedema—Memantine—Alzheimer's disease	0.000217	0.00101	CcSEcCtD
Formoterol—Dry mouth—Rivastigmine—Alzheimer's disease	0.000217	0.00101	CcSEcCtD
Formoterol—Insomnia—Donepezil—Alzheimer's disease	0.000217	0.00101	CcSEcCtD
Formoterol—Infection—Memantine—Alzheimer's disease	0.000216	0.001	CcSEcCtD
Formoterol—Dyspnoea—Donepezil—Alzheimer's disease	0.000214	0.000991	CcSEcCtD
Formoterol—Nervous system disorder—Memantine—Alzheimer's disease	0.000213	0.00099	CcSEcCtD
Formoterol—Somnolence—Donepezil—Alzheimer's disease	0.000213	0.000988	CcSEcCtD
Formoterol—Oedema—Rivastigmine—Alzheimer's disease	0.000213	0.000987	CcSEcCtD
Formoterol—Tachycardia—Memantine—Alzheimer's disease	0.000212	0.000985	CcSEcCtD
Formoterol—Diarrhoea—Galantamine—Alzheimer's disease	0.000211	0.000981	CcSEcCtD
Formoterol—Infection—Rivastigmine—Alzheimer's disease	0.000211	0.000981	CcSEcCtD
Formoterol—Skin disorder—Memantine—Alzheimer's disease	0.000211	0.00098	CcSEcCtD
Formoterol—Dyspepsia—Donepezil—Alzheimer's disease	0.000211	0.000978	CcSEcCtD
Formoterol—Nervous system disorder—Rivastigmine—Alzheimer's disease	0.000209	0.000968	CcSEcCtD
Formoterol—Tachycardia—Rivastigmine—Alzheimer's disease	0.000208	0.000964	CcSEcCtD
Formoterol—Gastrointestinal disorder—Donepezil—Alzheimer's disease	0.000207	0.00096	CcSEcCtD
Formoterol—Skin disorder—Rivastigmine—Alzheimer's disease	0.000207	0.000959	CcSEcCtD
Formoterol—Fatigue—Donepezil—Alzheimer's disease	0.000206	0.000958	CcSEcCtD
Formoterol—Pain—Donepezil—Alzheimer's disease	0.000205	0.00095	CcSEcCtD
Formoterol—Constipation—Donepezil—Alzheimer's disease	0.000205	0.00095	CcSEcCtD
Formoterol—Dizziness—Galantamine—Alzheimer's disease	0.000204	0.000948	CcSEcCtD
Formoterol—Hypotension—Memantine—Alzheimer's disease	0.000203	0.000943	CcSEcCtD
Formoterol—Hypotension—Rivastigmine—Alzheimer's disease	0.000199	0.000922	CcSEcCtD
Formoterol—Musculoskeletal discomfort—Memantine—Alzheimer's disease	0.000198	0.000919	CcSEcCtD
Formoterol—Feeling abnormal—Donepezil—Alzheimer's disease	0.000197	0.000916	CcSEcCtD
Formoterol—Insomnia—Memantine—Alzheimer's disease	0.000197	0.000913	CcSEcCtD
Formoterol—Vomiting—Galantamine—Alzheimer's disease	0.000196	0.000912	CcSEcCtD
Formoterol—Gastrointestinal pain—Donepezil—Alzheimer's disease	0.000196	0.000909	CcSEcCtD
Formoterol—Rash—Galantamine—Alzheimer's disease	0.000195	0.000904	CcSEcCtD
Formoterol—Dermatitis—Galantamine—Alzheimer's disease	0.000195	0.000903	CcSEcCtD
Formoterol—Dyspnoea—Memantine—Alzheimer's disease	0.000194	0.0009	CcSEcCtD
Formoterol—Musculoskeletal discomfort—Rivastigmine—Alzheimer's disease	0.000194	0.000899	CcSEcCtD
Formoterol—Headache—Galantamine—Alzheimer's disease	0.000194	0.000898	CcSEcCtD
Formoterol—Somnolence—Memantine—Alzheimer's disease	0.000193	0.000897	CcSEcCtD
Formoterol—Insomnia—Rivastigmine—Alzheimer's disease	0.000192	0.000893	CcSEcCtD
Formoterol—Dyspepsia—Memantine—Alzheimer's disease	0.000191	0.000888	CcSEcCtD
Formoterol—Urticaria—Donepezil—Alzheimer's disease	0.00019	0.000883	CcSEcCtD
Formoterol—Dyspnoea—Rivastigmine—Alzheimer's disease	0.00019	0.00088	CcSEcCtD
Formoterol—Body temperature increased—Donepezil—Alzheimer's disease	0.000189	0.000879	CcSEcCtD
Formoterol—Abdominal pain—Donepezil—Alzheimer's disease	0.000189	0.000879	CcSEcCtD
Formoterol—Somnolence—Rivastigmine—Alzheimer's disease	0.000189	0.000878	CcSEcCtD
Formoterol—Gastrointestinal disorder—Memantine—Alzheimer's disease	0.000188	0.000871	CcSEcCtD
Formoterol—Fatigue—Memantine—Alzheimer's disease	0.000187	0.00087	CcSEcCtD
Formoterol—Dyspepsia—Rivastigmine—Alzheimer's disease	0.000187	0.000869	CcSEcCtD
Formoterol—Pain—Memantine—Alzheimer's disease	0.000186	0.000863	CcSEcCtD
Formoterol—Constipation—Memantine—Alzheimer's disease	0.000186	0.000863	CcSEcCtD
Formoterol—Gastrointestinal disorder—Rivastigmine—Alzheimer's disease	0.000184	0.000852	CcSEcCtD
Formoterol—Nausea—Galantamine—Alzheimer's disease	0.000184	0.000852	CcSEcCtD
Formoterol—Fatigue—Rivastigmine—Alzheimer's disease	0.000183	0.000851	CcSEcCtD
Formoterol—Pain—Rivastigmine—Alzheimer's disease	0.000182	0.000844	CcSEcCtD
Formoterol—Constipation—Rivastigmine—Alzheimer's disease	0.000182	0.000844	CcSEcCtD
Formoterol—Feeling abnormal—Memantine—Alzheimer's disease	0.000179	0.000832	CcSEcCtD
Formoterol—Gastrointestinal pain—Memantine—Alzheimer's disease	0.000178	0.000825	CcSEcCtD
Formoterol—Hypersensitivity—Donepezil—Alzheimer's disease	0.000176	0.000819	CcSEcCtD
Formoterol—Feeling abnormal—Rivastigmine—Alzheimer's disease	0.000175	0.000814	CcSEcCtD
Formoterol—Gastrointestinal pain—Rivastigmine—Alzheimer's disease	0.000174	0.000807	CcSEcCtD
Formoterol—Urticaria—Memantine—Alzheimer's disease	0.000173	0.000802	CcSEcCtD
Formoterol—Abdominal pain—Memantine—Alzheimer's disease	0.000172	0.000798	CcSEcCtD
Formoterol—Body temperature increased—Memantine—Alzheimer's disease	0.000172	0.000798	CcSEcCtD
Formoterol—Asthenia—Donepezil—Alzheimer's disease	0.000172	0.000797	CcSEcCtD
Formoterol—Pruritus—Donepezil—Alzheimer's disease	0.000169	0.000786	CcSEcCtD
Formoterol—Urticaria—Rivastigmine—Alzheimer's disease	0.000169	0.000784	CcSEcCtD
Formoterol—Abdominal pain—Rivastigmine—Alzheimer's disease	0.000168	0.00078	CcSEcCtD
Formoterol—Body temperature increased—Rivastigmine—Alzheimer's disease	0.000168	0.00078	CcSEcCtD
Formoterol—Diarrhoea—Donepezil—Alzheimer's disease	0.000164	0.00076	CcSEcCtD
Formoterol—Labetalol—CYP2D6—Alzheimer's disease	0.00016	0.422	CrCbGaD
Formoterol—Hypersensitivity—Memantine—Alzheimer's disease	0.00016	0.000743	CcSEcCtD
Formoterol—Dizziness—Donepezil—Alzheimer's disease	0.000158	0.000735	CcSEcCtD
Formoterol—Hypersensitivity—Rivastigmine—Alzheimer's disease	0.000157	0.000727	CcSEcCtD
Formoterol—Asthenia—Memantine—Alzheimer's disease	0.000156	0.000724	CcSEcCtD
Formoterol—Pruritus—Memantine—Alzheimer's disease	0.000154	0.000714	CcSEcCtD
Formoterol—Asthenia—Rivastigmine—Alzheimer's disease	0.000153	0.000708	CcSEcCtD
Formoterol—Vomiting—Donepezil—Alzheimer's disease	0.000152	0.000707	CcSEcCtD
Formoterol—Rash—Donepezil—Alzheimer's disease	0.000151	0.000701	CcSEcCtD
Formoterol—Dermatitis—Donepezil—Alzheimer's disease	0.000151	0.0007	CcSEcCtD
Formoterol—Pruritus—Rivastigmine—Alzheimer's disease	0.000151	0.000698	CcSEcCtD
Formoterol—Headache—Donepezil—Alzheimer's disease	0.00015	0.000696	CcSEcCtD
Formoterol—Diarrhoea—Memantine—Alzheimer's disease	0.000149	0.00069	CcSEcCtD
Formoterol—Diarrhoea—Rivastigmine—Alzheimer's disease	0.000146	0.000675	CcSEcCtD
Formoterol—Dizziness—Memantine—Alzheimer's disease	0.000144	0.000667	CcSEcCtD
Formoterol—Nausea—Donepezil—Alzheimer's disease	0.000142	0.00066	CcSEcCtD
Formoterol—Dizziness—Rivastigmine—Alzheimer's disease	0.000141	0.000653	CcSEcCtD
Formoterol—Vomiting—Memantine—Alzheimer's disease	0.000138	0.000642	CcSEcCtD
Formoterol—Rash—Memantine—Alzheimer's disease	0.000137	0.000636	CcSEcCtD
Formoterol—Dermatitis—Memantine—Alzheimer's disease	0.000137	0.000636	CcSEcCtD
Formoterol—Headache—Memantine—Alzheimer's disease	0.000136	0.000632	CcSEcCtD
Formoterol—Vomiting—Rivastigmine—Alzheimer's disease	0.000135	0.000628	CcSEcCtD
Formoterol—Rash—Rivastigmine—Alzheimer's disease	0.000134	0.000622	CcSEcCtD
Formoterol—Dermatitis—Rivastigmine—Alzheimer's disease	0.000134	0.000622	CcSEcCtD
Formoterol—Headache—Rivastigmine—Alzheimer's disease	0.000133	0.000618	CcSEcCtD
Formoterol—Nausea—Memantine—Alzheimer's disease	0.000129	0.000599	CcSEcCtD
Formoterol—Nausea—Rivastigmine—Alzheimer's disease	0.000126	0.000586	CcSEcCtD
Formoterol—ADRB1—Signaling Pathways—LRP1—Alzheimer's disease	1.93e-05	0.000563	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—CYP46A1—Alzheimer's disease	1.91e-05	0.000557	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—PLD3—Alzheimer's disease	1.9e-05	0.000555	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—LRP1—Alzheimer's disease	1.89e-05	0.000551	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—GFAP—Alzheimer's disease	1.89e-05	0.00055	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—GAL—Alzheimer's disease	1.89e-05	0.00055	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—PLD3—Alzheimer's disease	1.89e-05	0.00055	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism of lipids and lipoproteins—ACHE—Alzheimer's disease	1.89e-05	0.00055	CbGpPWpGaD
Formoterol—CYP2A6—Metabolism—MAOB—Alzheimer's disease	1.87e-05	0.000545	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism of lipids and lipoproteins—INPP5D—Alzheimer's disease	1.87e-05	0.000544	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—GFAP—Alzheimer's disease	1.85e-05	0.000538	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—GAL—Alzheimer's disease	1.85e-05	0.000538	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—ND1—Alzheimer's disease	1.85e-05	0.000538	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—HSD17B10—Alzheimer's disease	1.83e-05	0.000532	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—HSD17B10—Alzheimer's disease	1.81e-05	0.000527	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism of lipids and lipoproteins—BCHE—Alzheimer's disease	1.8e-05	0.000526	CbGpPWpGaD
Formoterol—CYP2A6—Metabolism—GAPDH—Alzheimer's disease	1.8e-05	0.000525	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism of lipids and lipoproteins—PTGS1—Alzheimer's disease	1.77e-05	0.000515	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—CYP46A1—Alzheimer's disease	1.76e-05	0.000512	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—CYP46A1—Alzheimer's disease	1.74e-05	0.000508	CbGpPWpGaD
Formoterol—CYP2A6—Metabolism—A2M—Alzheimer's disease	1.74e-05	0.000507	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—ND1—Alzheimer's disease	1.7e-05	0.000495	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—ND1—Alzheimer's disease	1.68e-05	0.00049	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—A2M—Alzheimer's disease	1.66e-05	0.000485	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism of lipids and lipoproteins—ABCA1—Alzheimer's disease	1.65e-05	0.000481	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—Alzheimer's disease	1.65e-05	0.000479	CbGpPWpGaD
Formoterol—ADRB1—GPCR downstream signaling—PRKCG—Alzheimer's disease	1.64e-05	0.000478	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—A2M—Alzheimer's disease	1.63e-05	0.000474	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—PSEN2—Alzheimer's disease	1.61e-05	0.00047	CbGpPWpGaD
Formoterol—ADRB2—GPCR downstream signaling—PRKCG—Alzheimer's disease	1.61e-05	0.000468	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—PSEN2—Alzheimer's disease	1.58e-05	0.000459	CbGpPWpGaD
Formoterol—ADRB1—GPCR downstream signaling—CCR5—Alzheimer's disease	1.55e-05	0.000453	CbGpPWpGaD
Formoterol—ADRB1—GPCR downstream signaling—HTR2A—Alzheimer's disease	1.52e-05	0.000443	CbGpPWpGaD
Formoterol—ADRB2—GPCR downstream signaling—CCR5—Alzheimer's disease	1.52e-05	0.000443	CbGpPWpGaD
Formoterol—CYP2A6—Metabolism—ACHE—Alzheimer's disease	1.51e-05	0.000441	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism of lipids and lipoproteins—ABCA1—Alzheimer's disease	1.5e-05	0.000438	CbGpPWpGaD
Formoterol—CYP2A6—Metabolism—INPP5D—Alzheimer's disease	1.5e-05	0.000436	CbGpPWpGaD
Formoterol—ADRB1—Signaling by GPCR—PRKCG—Alzheimer's disease	1.49e-05	0.000434	CbGpPWpGaD
Formoterol—ADRB2—GPCR downstream signaling—HTR2A—Alzheimer's disease	1.49e-05	0.000434	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—NPY—Alzheimer's disease	1.48e-05	0.000432	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—IAPP—Alzheimer's disease	1.47e-05	0.00043	CbGpPWpGaD
Formoterol—ADRB2—Signaling by GPCR—PRKCG—Alzheimer's disease	1.46e-05	0.000425	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—NPY—Alzheimer's disease	1.45e-05	0.000423	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—IAPP—Alzheimer's disease	1.44e-05	0.00042	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—CRH—Alzheimer's disease	1.43e-05	0.000417	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism of lipids and lipoproteins—PPARGC1A—Alzheimer's disease	1.42e-05	0.000414	CbGpPWpGaD
Formoterol—CYP2A6—Metabolism—PTGS1—Alzheimer's disease	1.42e-05	0.000413	CbGpPWpGaD
Formoterol—CYP2A6—Metabolism—ENO1—Alzheimer's disease	1.42e-05	0.000413	CbGpPWpGaD
Formoterol—ADRB1—Signaling by GPCR—CCR5—Alzheimer's disease	1.41e-05	0.000411	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—CRH—Alzheimer's disease	1.4e-05	0.000408	CbGpPWpGaD
Formoterol—CYP2A6—Metabolism—CYP2D6—Alzheimer's disease	1.39e-05	0.000405	CbGpPWpGaD
Formoterol—ADRB1—Signaling by GPCR—HTR2A—Alzheimer's disease	1.38e-05	0.000403	CbGpPWpGaD
Formoterol—ADRB2—Signaling by GPCR—CCR5—Alzheimer's disease	1.38e-05	0.000402	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—NPS—Alzheimer's disease	1.36e-05	0.000395	CbGpPWpGaD
Formoterol—ADRB2—Signaling by GPCR—HTR2A—Alzheimer's disease	1.35e-05	0.000394	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—PPP3CA—Alzheimer's disease	1.35e-05	0.000393	CbGpPWpGaD
Formoterol—ADRB1—GPCR downstream signaling—F2—Alzheimer's disease	1.33e-05	0.000389	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—PTK2B—Alzheimer's disease	1.33e-05	0.000388	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—NPS—Alzheimer's disease	1.33e-05	0.000387	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—PPP3CA—Alzheimer's disease	1.32e-05	0.000385	CbGpPWpGaD
Formoterol—CYP2A6—Metabolism—BCHE—Alzheimer's disease	1.32e-05	0.000384	CbGpPWpGaD
Formoterol—ADRB2—GPCR downstream signaling—F2—Alzheimer's disease	1.3e-05	0.00038	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—PTK2B—Alzheimer's disease	1.3e-05	0.000379	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism of lipids and lipoproteins—PPARGC1A—Alzheimer's disease	1.3e-05	0.000378	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism of lipids and lipoproteins—LPL—Alzheimer's disease	1.29e-05	0.000377	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—GAB2—Alzheimer's disease	1.29e-05	0.000377	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—NTRK2—Alzheimer's disease	1.29e-05	0.000377	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—SST—Alzheimer's disease	1.29e-05	0.000377	CbGpPWpGaD
Formoterol—ADRB1—Signaling by GPCR—CALM1—Alzheimer's disease	1.29e-05	0.000376	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—GSK3A—Alzheimer's disease	1.28e-05	0.000374	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—SST—Alzheimer's disease	1.27e-05	0.000369	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—NTRK2—Alzheimer's disease	1.27e-05	0.000369	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—GAB2—Alzheimer's disease	1.27e-05	0.000369	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—APP—Alzheimer's disease	1.26e-05	0.000367	CbGpPWpGaD
Formoterol—ADRB2—Signaling by GPCR—CALM1—Alzheimer's disease	1.26e-05	0.000367	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—GSK3A—Alzheimer's disease	1.26e-05	0.000366	CbGpPWpGaD
Formoterol—CYP2A6—Metabolism—PLCB1—Alzheimer's disease	1.24e-05	0.000362	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—APP—Alzheimer's disease	1.23e-05	0.000359	CbGpPWpGaD
Formoterol—ADRB1—Signaling by GPCR—F2—Alzheimer's disease	1.21e-05	0.000353	CbGpPWpGaD
Formoterol—CYP2A6—Metabolism—ABCA1—Alzheimer's disease	1.21e-05	0.000351	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—PLCB1—Alzheimer's disease	1.19e-05	0.000347	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—TPI1—Alzheimer's disease	1.19e-05	0.000347	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—CHAT—Alzheimer's disease	1.19e-05	0.000347	CbGpPWpGaD
Formoterol—ADRB2—Signaling by GPCR—F2—Alzheimer's disease	1.19e-05	0.000345	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism of lipids and lipoproteins—LPL—Alzheimer's disease	1.18e-05	0.000344	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—PLCB1—Alzheimer's disease	1.16e-05	0.000339	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—MAOB—Alzheimer's disease	1.14e-05	0.000332	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—NGFR—Alzheimer's disease	1.11e-05	0.000324	CbGpPWpGaD
Formoterol—ADRB1—Signaling by GPCR—CREB1—Alzheimer's disease	1.1e-05	0.000321	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—GAPDH—Alzheimer's disease	1.1e-05	0.00032	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—CHAT—Alzheimer's disease	1.09e-05	0.000319	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—TPI1—Alzheimer's disease	1.09e-05	0.000319	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—NGFR—Alzheimer's disease	1.09e-05	0.000316	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism of lipids and lipoproteins—APOE—Alzheimer's disease	1.09e-05	0.000316	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—ADAM10—Alzheimer's disease	1.08e-05	0.000316	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—CHAT—Alzheimer's disease	1.08e-05	0.000316	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—TPI1—Alzheimer's disease	1.08e-05	0.000316	CbGpPWpGaD
Formoterol—ADRB1—Signaling by GPCR—CCL2—Alzheimer's disease	1.08e-05	0.000315	CbGpPWpGaD
Formoterol—ADRB2—Signaling by GPCR—CREB1—Alzheimer's disease	1.08e-05	0.000314	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism of lipids and lipoproteins—CAV1—Alzheimer's disease	1.08e-05	0.000313	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—ADAM10—Alzheimer's disease	1.06e-05	0.000309	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—A2M—Alzheimer's disease	1.06e-05	0.000309	CbGpPWpGaD
Formoterol—ADRB2—Signaling by GPCR—CCL2—Alzheimer's disease	1.06e-05	0.000308	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—MAOB—Alzheimer's disease	1.05e-05	0.000306	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—MAOB—Alzheimer's disease	1.04e-05	0.000303	CbGpPWpGaD
Formoterol—CYP2A6—Metabolism—PPARGC1A—Alzheimer's disease	1.04e-05	0.000303	CbGpPWpGaD
Formoterol—CYP2A6—Metabolism—HMOX1—Alzheimer's disease	1.03e-05	0.000301	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—S100B—Alzheimer's disease	1.03e-05	0.000299	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—GAPDH—Alzheimer's disease	1.01e-05	0.000294	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—S100B—Alzheimer's disease	1e-05	0.000292	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—GAPDH—Alzheimer's disease	1e-05	0.000292	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism of lipids and lipoproteins—APOE—Alzheimer's disease	9.9e-06	0.000288	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—Alzheimer's disease	9.81e-06	0.000286	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—IGF2—Alzheimer's disease	9.77e-06	0.000285	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—A2M—Alzheimer's disease	9.75e-06	0.000284	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—A2M—Alzheimer's disease	9.67e-06	0.000282	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—IGF2—Alzheimer's disease	9.55e-06	0.000278	CbGpPWpGaD
Formoterol—CYP2A6—Metabolism—LPL—Alzheimer's disease	9.46e-06	0.000276	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—Alzheimer's disease	9.45e-06	0.000275	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—IGF1R—Alzheimer's disease	9.44e-06	0.000275	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—IGF1R—Alzheimer's disease	9.24e-06	0.000269	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—ACHE—Alzheimer's disease	9.22e-06	0.000269	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—INPP5D—Alzheimer's disease	9.12e-06	0.000266	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—LPL—Alzheimer's disease	9.05e-06	0.000264	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—MEF2C—Alzheimer's disease	8.97e-06	0.000261	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—LPL—Alzheimer's disease	8.86e-06	0.000258	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—PRKCG—Alzheimer's disease	8.8e-06	0.000256	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—MEF2C—Alzheimer's disease	8.78e-06	0.000256	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—ENO1—Alzheimer's disease	8.64e-06	0.000252	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—PTGS1—Alzheimer's disease	8.64e-06	0.000252	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—Alzheimer's disease	8.62e-06	0.000251	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—PRKCG—Alzheimer's disease	8.61e-06	0.000251	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—NGF—Alzheimer's disease	8.57e-06	0.00025	CbGpPWpGaD
Formoterol—CYP2A6—Metabolism—MTHFR—Alzheimer's disease	8.52e-06	0.000248	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—ACHE—Alzheimer's disease	8.48e-06	0.000247	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—CYP2D6—Alzheimer's disease	8.48e-06	0.000247	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—ACHE—Alzheimer's disease	8.41e-06	0.000245	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—NGF—Alzheimer's disease	8.39e-06	0.000244	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—INPP5D—Alzheimer's disease	8.39e-06	0.000244	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—CCR5—Alzheimer's disease	8.34e-06	0.000243	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—INPP5D—Alzheimer's disease	8.31e-06	0.000242	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—HTR2A—Alzheimer's disease	8.16e-06	0.000238	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—CCR5—Alzheimer's disease	8.16e-06	0.000238	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—BCHE—Alzheimer's disease	8.04e-06	0.000234	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—HTR2A—Alzheimer's disease	7.98e-06	0.000233	CbGpPWpGaD
Formoterol—CYP2A6—Metabolism—CALM1—Alzheimer's disease	7.96e-06	0.000232	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—PTGS1—Alzheimer's disease	7.95e-06	0.000232	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—ENO1—Alzheimer's disease	7.95e-06	0.000232	CbGpPWpGaD
Formoterol—CYP2A6—Metabolism—APOE—Alzheimer's disease	7.93e-06	0.000231	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—PTGS1—Alzheimer's disease	7.88e-06	0.00023	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—ENO1—Alzheimer's disease	7.88e-06	0.00023	CbGpPWpGaD
Formoterol—CYP2A6—Metabolism—CAV1—Alzheimer's disease	7.86e-06	0.000229	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—CYP2D6—Alzheimer's disease	7.73e-06	0.000225	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—CALM1—Alzheimer's disease	7.62e-06	0.000222	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—LEP—Alzheimer's disease	7.59e-06	0.000221	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—APOE—Alzheimer's disease	7.59e-06	0.000221	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—PLCB1—Alzheimer's disease	7.58e-06	0.000221	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—CAV1—Alzheimer's disease	7.52e-06	0.000219	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—CALM1—Alzheimer's disease	7.45e-06	0.000217	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—Alzheimer's disease	7.44e-06	0.000217	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—APOE—Alzheimer's disease	7.42e-06	0.000216	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—LEP—Alzheimer's disease	7.42e-06	0.000216	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—BCHE—Alzheimer's disease	7.39e-06	0.000215	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—CAV1—Alzheimer's disease	7.36e-06	0.000214	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—ABCA1—Alzheimer's disease	7.35e-06	0.000214	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—BCHE—Alzheimer's disease	7.33e-06	0.000213	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—ESR1—Alzheimer's disease	7.25e-06	0.000211	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—F2—Alzheimer's disease	7.16e-06	0.000208	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—ESR1—Alzheimer's disease	7.09e-06	0.000206	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—NOTCH1—Alzheimer's disease	7e-06	0.000204	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—F2—Alzheimer's disease	7e-06	0.000204	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—PLCB1—Alzheimer's disease	6.97e-06	0.000203	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—PLCB1—Alzheimer's disease	6.91e-06	0.000201	CbGpPWpGaD
Formoterol—CYP2A6—Metabolism—PPARG—Alzheimer's disease	6.91e-06	0.000201	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—NOTCH1—Alzheimer's disease	6.85e-06	0.0002	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—Alzheimer's disease	6.78e-06	0.000198	CbGpPWpGaD
Formoterol—CYP2A6—Metabolism—INS—Alzheimer's disease	6.77e-06	0.000197	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—ABCA1—Alzheimer's disease	6.76e-06	0.000197	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—ABCA1—Alzheimer's disease	6.7e-06	0.000195	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—GSK3B—Alzheimer's disease	6.57e-06	0.000191	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—CREB1—Alzheimer's disease	6.52e-06	0.00019	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—INS—Alzheimer's disease	6.48e-06	0.000189	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—GSK3B—Alzheimer's disease	6.43e-06	0.000187	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—CCL2—Alzheimer's disease	6.38e-06	0.000186	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—CREB1—Alzheimer's disease	6.38e-06	0.000186	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—INS—Alzheimer's disease	6.34e-06	0.000185	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—PPARGC1A—Alzheimer's disease	6.33e-06	0.000185	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—HMOX1—Alzheimer's disease	6.31e-06	0.000184	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—IGF1—Alzheimer's disease	6.27e-06	0.000183	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—CCL2—Alzheimer's disease	6.24e-06	0.000182	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—IGF1—Alzheimer's disease	6.13e-06	0.000179	CbGpPWpGaD
Formoterol—CYP2A6—Metabolism—NOS3—Alzheimer's disease	5.94e-06	0.000173	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—PPARGC1A—Alzheimer's disease	5.83e-06	0.00017	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—HMOX1—Alzheimer's disease	5.8e-06	0.000169	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—PPARGC1A—Alzheimer's disease	5.78e-06	0.000168	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—LPL—Alzheimer's disease	5.77e-06	0.000168	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—HMOX1—Alzheimer's disease	5.75e-06	0.000167	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—NOS3—Alzheimer's disease	5.69e-06	0.000166	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—NOS3—Alzheimer's disease	5.56e-06	0.000162	CbGpPWpGaD
Formoterol—CYP2A6—Metabolism—PTGS2—Alzheimer's disease	5.43e-06	0.000158	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—LPL—Alzheimer's disease	5.3e-06	0.000155	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—LPL—Alzheimer's disease	5.26e-06	0.000153	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—MTHFR—Alzheimer's disease	5.19e-06	0.000151	CbGpPWpGaD
Formoterol—ADRB1—GPCR downstream signaling—AKT1—Alzheimer's disease	4.87e-06	0.000142	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—CALM1—Alzheimer's disease	4.85e-06	0.000141	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—APOE—Alzheimer's disease	4.83e-06	0.000141	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—CASP3—Alzheimer's disease	4.83e-06	0.000141	CbGpPWpGaD
Formoterol—ADRB1—Signaling by GPCR—IL6—Alzheimer's disease	4.8e-06	0.00014	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—CAV1—Alzheimer's disease	4.79e-06	0.00014	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—MTHFR—Alzheimer's disease	4.78e-06	0.000139	CbGpPWpGaD
Formoterol—ADRB2—GPCR downstream signaling—AKT1—Alzheimer's disease	4.77e-06	0.000139	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—MTHFR—Alzheimer's disease	4.73e-06	0.000138	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—CASP3—Alzheimer's disease	4.72e-06	0.000138	CbGpPWpGaD
Formoterol—ADRB2—Signaling by GPCR—IL6—Alzheimer's disease	4.69e-06	0.000137	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—CALM1—Alzheimer's disease	4.46e-06	0.00013	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—APOE—Alzheimer's disease	4.45e-06	0.00013	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—MAPK8—Alzheimer's disease	4.44e-06	0.000129	CbGpPWpGaD
Formoterol—ADRB1—Signaling by GPCR—AKT1—Alzheimer's disease	4.42e-06	0.000129	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—CALM1—Alzheimer's disease	4.42e-06	0.000129	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—APOE—Alzheimer's disease	4.41e-06	0.000128	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—CAV1—Alzheimer's disease	4.4e-06	0.000128	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—CAV1—Alzheimer's disease	4.37e-06	0.000127	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—MAPK8—Alzheimer's disease	4.34e-06	0.000126	CbGpPWpGaD
Formoterol—ADRB2—Signaling by GPCR—AKT1—Alzheimer's disease	4.33e-06	0.000126	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—PPARG—Alzheimer's disease	4.21e-06	0.000123	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—INS—Alzheimer's disease	4.13e-06	0.00012	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—VEGFA—Alzheimer's disease	4.1e-06	0.000119	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—VEGFA—Alzheimer's disease	4.01e-06	0.000117	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—PPARG—Alzheimer's disease	3.87e-06	0.000113	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—PPARG—Alzheimer's disease	3.84e-06	0.000112	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—INS—Alzheimer's disease	3.8e-06	0.000111	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—INS—Alzheimer's disease	3.77e-06	0.00011	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—TGFB1—Alzheimer's disease	3.76e-06	0.00011	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—TGFB1—Alzheimer's disease	3.68e-06	0.000107	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—NOS3—Alzheimer's disease	3.62e-06	0.000105	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—NOS3—Alzheimer's disease	3.33e-06	9.7e-05	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—PTGS2—Alzheimer's disease	3.31e-06	9.65e-05	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—NOS3—Alzheimer's disease	3.3e-06	9.62e-05	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—TP53—Alzheimer's disease	3.09e-06	9.02e-05	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—PTGS2—Alzheimer's disease	3.05e-06	8.87e-05	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—TP53—Alzheimer's disease	3.03e-06	8.82e-05	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—PTGS2—Alzheimer's disease	3.02e-06	8.8e-05	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—IL6—Alzheimer's disease	2.83e-06	8.25e-05	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—IL6—Alzheimer's disease	2.77e-06	8.07e-05	CbGpPWpGaD
Formoterol—CYP2A6—Metabolism—AKT1—Alzheimer's disease	2.73e-06	7.95e-05	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—AKT1—Alzheimer's disease	2.61e-06	7.61e-05	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—AKT1—Alzheimer's disease	2.56e-06	7.45e-05	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—AKT1—Alzheimer's disease	1.66e-06	4.85e-05	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—AKT1—Alzheimer's disease	1.53e-06	4.46e-05	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—AKT1—Alzheimer's disease	1.52e-06	4.42e-05	CbGpPWpGaD
